Instruction for use: Immunal

Dosage form: Solution for oral administration; tablets

Active substance: Succus herbae Echinaceae purpurae

ATX

L03AX Other immunostimulants

Pharmacological group:

Immunostimulating agent of vegetable origin [Other immunomodulators]

The nosological classification (ICD-10)

B99 Other infectious diseases: Infections (opportunistic); Infections on the background of immunodeficiency; Opportunistic infections

D84.9 Unspecified Immunodeficiency: Pneumonia in immunodeficient states; Autoimmune disease; Autoimmune diseases; Severe immunodeficiency; immune deficiency; Immunodeficiency; immunodeficiency diseases; Immunodeficiency states due to surgery; Immunotherapy for cancer; Immunomodulation; Infections in patients with weakened immune systems; Correction of immune deficiency; Correction of immunodeficiencies; Correction of a weakened immune system; Correction of a weakened immunity in immunodeficient states; Violation of immunity; Violation of the immune status; Immune System Disorders; Primary immunodeficiency; Maintaining immunity; Lowering the body's defenses; Lowering the immunity; Lowering the immunity of colds and infectious diseases; The decrease of the immune status; Lowered resistance to infections; Lowered resistance to infections and colds; Lowered resistance; Immunosuppression; Predisposition to colds; acquired immune deficiencies; Radiation immunodeficiency; The development of immunodeficiency; Immune dysfunction syndrome; immunodeficiency syndrome; primary immunodeficiency syndrome; Reducing the body's defenses; Immunosuppression; Reduced immune defense; Reducing local immunity; Reducing the total body resistance; The decrease in cell-mediated immunity; Reduced resistance to infections in children; Reducing the body's resistance; Reduced resistance; reduced immunity; Status immunodeficiency; Stimulation of the processes of nonspecific immunity; Heavy selective secondary immunodeficiency; immunity Oppression; Primary immunodeficiency

J06 Acute upper respiratory tract infections of multiple and unspecified locations: Frequent colds of viral diseases; Infections of ENT organs; Acute respiratory illness of influenza nature; Pain for colds; Acute catarrhal disease; Cold; Colds; Colds; Respiratory infection; Seasonal catarrhal disease; Seasonal colds; Pain in infectious and inflammatory diseases of the upper respiratory tract; Bacterial infections of the upper respiratory tract; Bacterial infections of the respiratory system; Viral respiratory disease; Viral respiratory tract infections; Inflammatory disease of the upper respiratory tract; Inflammatory diseases of the upper respiratory tract; Inflammatory diseases of the upper respiratory tract with difficult to separate sputum; Inflammatory respiratory disease; Secondary infections for colds; Difficult sputum separation in acute and chronic respiratory diseases; Upper respiratory tract infections; Infections of the upper respiratory tract; Respiratory tract infections; Respiratory and lung infections; Infectious-inflammatory diseases of the upper respiratory tract; Infectious-inflammatory diseases of the upper respiratory tract and ENT organs; Infectious-inflammatory diseases of the upper respiratory tract in adults and children; Infectious-inflammatory diseases of the upper respiratory tract; Infectious inflammation of the respiratory tract; Respiratory tract infection; Qatar upper respiratory tract; Catarrh of the upper respiratory tract; Catarrh of the upper respiratory tract; Catarrhal phenomena from the upper respiratory tract; Cough in diseases of the upper respiratory tract; Cough for colds; ARVI; ARI; ARI with phenomena of rhinitis; Acute respiratory infection; Acute infectious-inflammatory disease of the upper respiratory tract; Acute respiratory disease; Persecution in the throat or nose; Respiratory and viral infections; Respiratory diseases; Respiratory infections; Recurrent respiratory tract infections; Secondary infections with influenza; Influenza states; Feverish conditions for influenza

J11 Influenza, virus not identified: Influenza; Influenza in the early stages of the disease; Influenza in children; cold in the chest; Begins flu-like condition; Acute disease parainfluenza; parainfluenza; parainfluenza state; influenza epidemics; The pains of the influenza

Y40 Adverse reactions in the therapeutic use of systemic action antibiotics

Composition

Solution for oral administration 1 ml

active substance: Echinacea purpurea (Echinacea purpurea (L.) Moench) juice 0.8 ml

Auxiliary substances: ethanol; sorbitol

Tablets - 1 table.

active substance: Echinacea purpurea (Echinacea purpurea (L.) Moench) juice dried 80 mg

Auxiliary substances: silicon colloidal dioxide; lactose; Magnesium stearate; Sodium saccharinate; vanillin; Aromatic cherry

Description of dosage form

Solution for oral administration: from a clear to cloudy solution of brown color. During the storage, the formation of a flocculent deposit is acceptable.

Tablets: round planocylindrical, light brown with impregnations, with the smell of vanilla.

Pharmachologic effect

Mode of action - Immunosuppressive.

Pharmacodynamics

Immunal® is an immunostimulating drug made from medicinal plant material.

Echinacea purpurea (Echinacea purpurea (L.) Moench) contains active substances that enhance the natural defenses of the body and act as stimulants of immunity.

By increasing the number of leukocytes (granulocytes) and activating phagocytosis, the active substances of the drug suppress the reproduction of microorganisms in the human body and contribute to the destruction of pathogenic bacteria. In addition, the antiviral effect of the herb of Echinacea purpurea has been established for the causative agents of influenza and herpes.

Indication of the Immunal

Immunal® is recommended for:

To strengthen immunity in patients with uncomplicated acute infectious diseases, a predisposition to frequent colds;

For the prevention of colds and flu;

As an auxiliary drug for prolonged antibiotic therapy of chronic infectious diseases, accompanied by a decrease in immunity.

Contraindications

Hypersensitivity to the components of the drug and plants of the family Compositae;

Progressive systemic and autoimmune diseases, such as tuberculosis, leukemia, collagenoses, multiple sclerosis, AIDS or HIV infection;

Children under 1 year (for oral solution) or up to 4 years (for tablets).

Application in pregnancy and breastfeeding

Data on the adverse effects of the Immunal® preparation are not available. Before using the drug during pregnancy and during breastfeeding it is necessary to consult a doctor in charge.

Side effects

In some cases, the development of reactions of hypersensitivity: skin rash, itching, dizziness, bronchospasm, angioedema, Stevens-Johnson syndrome, anaphylactic shock.

Other: leukopenia (with continuous use for more than 8 weeks).

Interaction

Solution for oral administration. Immunal® contains alcohol, so the drug can enhance or alter the effect of other drugs. Clinically significant interactions are noted with the simultaneous use of each of the following five cephalosporin derivatives (cefamandol, cefotetan, cefmenoxime, cefaferazone and moxalactam) and alcohol (even in small amounts). The patient's reaction was characterized by reddening of the face, nausea, sweating, headache and palpitations. In this regard, Immunal® solution for oral administration should not be used in the treatment of patients with these antibiotics. The administration of Immunal® is allowed only three days after the end of the course of treatment with the above cephalosporin derivatives.

Tablets. With simultaneous reception with immunosuppressants - mutual weakening of the action.

There are no reports of any clinically relevant interaction with other drugs.

Dosing and Administration

Inside.

Solution for oral administration

To facilitate correct dosing, a graduated metering pipette is enclosed in each package.

Before taking the right amount of the drug should be diluted in a small volume of water.

Adults and adolescents over 12 years of age: 2.5 ml of oral solution 3 times a day. Children aged 6 to 12 years - 1.5 ml of oral solution 3 times a day; Children aged 1 to 6 years: 1 ml of oral solution 3 times a day.

Tablets

For small children, it is recommended to crush the tablet and mix with a small amount of liquid. Adults and adolescents over 12 years of age: 1 table. 3-4 times a day; Children aged 6 to 12 years: 1 table. 1-3 times a day; Children aged 4 to 6 years: 1 table. 1-2 times a day.

To achieve a therapeutic effect, Immunal® should be taken for at least 1 week. The duration of a continuous course of treatment should not exceed 8 weeks.

Overdose

Symptoms of intoxication due to drug overdose are not noted.

Special instructions

Before applying Immunal® in children under 12 and patients with allergic diseases and bronchial asthma in a history, you should consult your doctor.

In case of side effects, stop taking Immunal® and consult a doctor.

If symptoms persist for more than 10 days, consult your doctor.

Immunal® oral solution contains 20% ethanol (ie the alcohol content in the maximum single dose is equivalent to 1 tsp dry wine). When stored, the precipitation of a flocculent precipitate consisting of active polysaccharides is acceptable. Shake the bottle thoroughly before use.

Effect on the ability to concentrate. When taking the drug at recommended doses, no special precautions are required.

Release form

Solution for oral administration. For 50 ml of the drug in a vial of dark glass, 1 vial. Complete with a dosage pipette in a cardboard box.

Tablets. By 10 or 20 tables. In a blister, 2 blisters (10 tablets each) or 1 blister (20 tablets each) in a cardboard bundle.

Manufacturer

Lek dd Verovshkova 57, Ljubljana, Slovenia.

Claims of consumers to send to ZAO Sandoz

Conditions of supply of pharmacies

Without recipe.

Storage conditions of the drug Immunal

At a temperature no higher than 25 ° C.

Keep out of the reach of children.

Shelf life of the drug Immunal

Tablets - 3 years.

Solution for oral administration - 2 years.

Do not use after the expiry date printed on the package.